Skip to content
Back to main page

VAIOMER

About

VAIOMER microbiome science stimulates the discovery of new disease mechanisms, new biomarkers to contribute to personalized medecine, new pathways to identify novel therapeutic targets.

Join the move

Joined the move

VAIOMER has joined the move since 02/02/2011.

Cash Invested

TEMA has invested 10.000€ in VAIOMER.

Know more about Vaiomer

Vaiomer microbiome science stimulates the discovery of new disease mechanisms, new biomarkers to contribute to personalized medecine, new pathways to identify novel therapeutic targets.

The gut microbiome hides so many secrets for life. uncovering such mysteries should be the spring of a better life. Predicting, diagnosing, treating diseases by targeting the cause rather than the consequence is a wining strategy. We got envolved in this company thanks to their leaders who made us dream of a better pharmaceutical strategy where drugs will be safe and efficient since targeting the cause (the microbiome) rather than the consequence of the disease. A microbiota based company that will be a cornerstone for our better future.

Go to website